![](/img/cover-not-exists.png)
757P An observational study of outcomes of patients (pts) with advanced urothelial carcinoma (UC) after anti-programmed death-(Ligand) 1 (PD-[L]1) therapy by fibroblast growth factor receptor gene alteration (FGFRa) status
Rezazadeh, A., Loriot, Y., Papantoniou, D., Siefker-Radtke, A.O., Necchi, A., Naini, V., Santiago-Walker, A., Galluzzi, A., Monga, M., Burgess, E.F.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.829
Date:
September, 2020
File:
PDF, 122 KB
2020